rs755821176
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001830.4(CLCN4):c.1107G>A(p.Pro369Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000579 in 1,208,875 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., 8 hem., cov: 22)
Exomes 𝑓: 0.000039 ( 0 hom. 13 hem. )
Consequence
CLCN4
NM_001830.4 synonymous
NM_001830.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.83
Genes affected
CLCN4 (HGNC:2022): (chloride voltage-gated channel 4) The CLCN family of voltage-dependent chloride channel genes comprises nine members (CLCN1-7, Ka and Kb) which demonstrate quite diverse functional characteristics while sharing significant sequence homology. Chloride channel 4 has an evolutionary conserved CpG island and is conserved in both mouse and hamster. This gene is mapped in close proximity to APXL (Apical protein Xenopus laevis-like) and OA1 (Ocular albinism type I), which are both located on the human X chromosome at band p22.3. The physiological role of chloride channel 4 remains unknown but may contribute to the pathogenesis of neuronal disorders. Alternate splicing results in two transcript variants that encode different proteins. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant X-10208308-G-A is Benign according to our data. Variant chrX-10208308-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 415734.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.83 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000244 (27/110688) while in subpopulation AFR AF= 0.000658 (20/30402). AF 95% confidence interval is 0.000435. There are 0 homozygotes in gnomad4. There are 8 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 8 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCN4 | NM_001830.4 | c.1107G>A | p.Pro369Pro | synonymous_variant | 9/13 | ENST00000380833.9 | NP_001821.2 | |
CLCN4 | NM_001256944.2 | c.825G>A | p.Pro275Pro | synonymous_variant | 7/11 | NP_001243873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCN4 | ENST00000380833.9 | c.1107G>A | p.Pro369Pro | synonymous_variant | 9/13 | 1 | NM_001830.4 | ENSP00000370213.4 |
Frequencies
GnomAD3 genomes AF: 0.000244 AC: 27AN: 110632Hom.: 0 Cov.: 22 AF XY: 0.000244 AC XY: 8AN XY: 32854
GnomAD3 genomes
AF:
AC:
27
AN:
110632
Hom.:
Cov.:
22
AF XY:
AC XY:
8
AN XY:
32854
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000655 AC: 12AN: 183277Hom.: 0 AF XY: 0.0000738 AC XY: 5AN XY: 67729
GnomAD3 exomes
AF:
AC:
12
AN:
183277
Hom.:
AF XY:
AC XY:
5
AN XY:
67729
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000392 AC: 43AN: 1098187Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 13AN XY: 363543
GnomAD4 exome
AF:
AC:
43
AN:
1098187
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
363543
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000244 AC: 27AN: 110688Hom.: 0 Cov.: 22 AF XY: 0.000243 AC XY: 8AN XY: 32920
GnomAD4 genome
AF:
AC:
27
AN:
110688
Hom.:
Cov.:
22
AF XY:
AC XY:
8
AN XY:
32920
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 25, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 12, 2021 | - - |
CLCN4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 26, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at